GTHP
Price:
$0.203
Market Cap:
$15.57M
Guided Therapeutics, Inc. is a medical technology firm specializing in the creation of medical devices. Its primary focus is on bringing to market LuViva, an innovative device designed for the non-invasive detection of cervical cancer. This technology excels at identifying both cancerous and precancerous conditions of the cervix in a painless, non-invasive manner, directly at the point of care. LuViva operates by scanning the cervix with light and subsequently analyzing both the reflected and fluorescent light emitted. Established in 1992 and headquartered in Norcross, Georgia, the company was formerly known as SpectRx, Inc. until its rebranding to Guided Therapeutics, Inc. in February 2008.
Industry
Medical - Devices
IPO Date
2021-01-08
Stock Exchange
OTC
Ticker
GTHP
According to Guided Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -5.07. This represents a change of -20.39% compared to the average of -6.37 of the last 4 quarters.
The mean historical PE Ratio of Guided Therapeutics, Inc. over the last ten years is -3.91. The current -5.07 PE Ratio has changed 12.87% with respect to the historical average. Over the past ten years (40 quarters), GTHP's PE Ratio was at its highest in in the September 2021 quarter at 27.62. The PE Ratio was at its lowest in in the December 2025 quarter at -7.75.
Average
-3.91
Median
-2.25
Minimum
-13.61
Maximum
0.16
Discovering the peaks and valleys of Guided Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 48.35%
Maximum Annual PE Ratio = 0.16
Minimum Annual Increase = -44315.75%
Minimum Annual PE Ratio = -13.61
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -13.25 | 272.32% |
| 2024 | -3.56 | 58.19% |
| 2023 | -2.25 | 0.14% |
| 2022 | -2.25 | -40.07% |
| 2021 | -3.75 | -72.45% |
| 2020 | -13.61 | 2.15% |
| 2019 | -0.61 | -478.01% |
| 2018 | 0.16 | -44315.75% |
| 2017 | -0.00 | 388.38% |
| 2016 | -0.00 | 48.35% |
The current PE Ratio of Guided Therapeutics, Inc. (GTHP) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-6.35
5-year avg
-5.01
10-year avg
-3.91
Guided Therapeutics, Inc.’s PE Ratio is less than Biotricity, Inc. (-0.82), greater than Aurora Spine Corporation (-21.66), less than Perimeter Medical Imaging AI, Inc. (-2.22), greater than CareView Communications, Inc. (-9.62), greater than Elbit Imaging Ltd. (-12.27), greater than United Health Products, Inc. (-9.97), less than AccuStem Sciences Limited (-0.00), greater than VentriPoint Diagnostics Ltd. (-6.08), less than Immunovia AB (publ) (-1.13), less than Zenith Capital Corp. (-1.51),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.82 | $3.41M | |
| -21.66 | $12.32M | |
| -2.22 | $19.52M | |
| -9.62 | $29.19M | |
| -12.27 | $21.25M | |
| -9.97 | $14.58M | |
| -0.00 | $0 | |
| -6.08 | $15.14M | |
| -1.13 | $6.11M | |
| -1.51 | $7.99M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Guided Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Guided Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Guided Therapeutics, Inc.'s PE Ratio?
How is the PE Ratio calculated for Guided Therapeutics, Inc. (GTHP)?
What is the highest PE Ratio for Guided Therapeutics, Inc. (GTHP)?
What is the 3-year average PE Ratio for Guided Therapeutics, Inc. (GTHP)?
What is the 5-year average PE Ratio for Guided Therapeutics, Inc. (GTHP)?
How does the current PE Ratio for Guided Therapeutics, Inc. (GTHP) compare to its historical average?